JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4,096 Cr | ₹4,006 Cr | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr |
What is the latest Total Non-Current Liabilities ratio of JUBILANT PHARMOVA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4,096 Cr |
| Mar2024 | ₹4,006 Cr |
| Mar2023 | ₹3,765 Cr |
| Mar2022 | ₹2,922 Cr |
| Mar2021 | ₹2,973 Cr |
How is Total Non-Current Liabilities of JUBILANT PHARMOVA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,096 Cr | 2.25 | |
| Mar2024 | ₹4,006 Cr | 6.39 | |
| Mar2023 | ₹3,765 Cr | 28.87 | |
| Mar2022 | ₹2,922 Cr | -1.73 | |
| Mar2021 | ₹2,973 Cr | - | |
Compare Total Non-Current Liabilities of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹15,828.0 Cr | -5.4% | -5.1% | 8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -5.4% |
-5.1% |
8.8% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses